Extracellular Vesicles: Recent Advances and Perspectives.
Level 5 - mechanism / opinion, no new human data
Narrative review of biological mechanisms, isolation techniques, and applications with no new human data or systematic synthesis.
PubMed 40613286 · doi:10.31083/FBL36405
What was done
The authors conducted a narrative review summarizing extracellular vesicle (EV) subtypes (exosomes, microvesicles, apoptotic bodies), biogenesis, composition, and cellular uptake pathways. The paper examines isolation techniques (ultracentrifugation, size-exclusion chromatography, immunoaffinity), characterization platforms (nanoparticle tracking, electron microscopy, omics), and their diagnostic and drug-delivery applications across oncology, neurodegeneration, and musculoskeletal diseases.
What was found
The abstract provides a qualitative overview and reports no quantitative findings, effect sizes, or performance metrics. It identifies EV cargo (proteins, lipids, RNA, DNA, metabolites) as stable disease-specific biomarkers and highlights their biocompatibility for therapeutic delivery, while noting ongoing obstacles in manufacturing scale-up, targeting precision, and regulatory pathways.
Why it matters
This paper consolidates recent technical and biological developments in the extracellular vesicle field, framing their potential as non-invasive diagnostics and targeted delivery systems in precision medicine.
Limits
The paper is a non-systematic narrative review providing no primary experimental data or statistical synthesis. The abstract reports no comparative yields, diagnostic sensitivity/specificity metrics, or therapeutic efficacy numbers across specific clinical contexts.
Cited by
- supports Exosomes are extracellular vesicles released by cells that contain proteins, RNA molecules, lipids, and metabolites, and they circulate in large numbers in the blood.